论文部分内容阅读
一、心血管系统药物Quazodine 心肌疾患是一个日益重要的临床问题,目前治疗上有效的新药已逐步增多。例如:6,7—二甲氧基—4—乙基喹唑啉,即Quazodine,经用于实验性心肌梗塞的动物,证明Quazodine能明显地增加受损心肌组织的血流量,也可以增加心肌的收缩力。本品的作用和某些其它心肌兴奋剂不同,它能改善心脏功能,但不致增加心肌需氧量,同时因心肌血流量较多,致使左心室舒张压下降。本品是否能成为有效的治疗
First, the cardiovascular system drugs Quazodine myocardial disease is an increasingly important clinical problem, the current treatment of effective new drugs have been gradually increased. For example: 6,7-Dimethoxy-4-ethylquinazoline, Quazodine, used in experimental myocardial infarction animals, shows that Quazodine can significantly increase the blood flow of damaged myocardial tissue, can also increase myocardial Contractility. The role of this product and some other myocardial stimulants different, it can improve cardiac function, but will not increase myocardial oxygen demand, while more myocardial blood flow, resulting in decreased left ventricular diastolic blood pressure. This product can become effective treatment